A detailed history of State Of Wyoming transactions in Gossamer Bio, Inc. stock. As of the latest transaction made, State Of Wyoming holds 242,649 shares of GOSS stock, worth $186,839. This represents 0.04% of its overall portfolio holdings.

Number of Shares
242,649
Holding current value
$186,839
% of portfolio
0.04%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$0.79 - $1.25 $191,692 - $303,311
242,649 New
242,649 $240,000
Q2 2022

Aug 15, 2022

SELL
$5.97 - $9.97 $32,620 - $54,476
-5,464 Closed
0 $0
Q1 2022

May 13, 2022

BUY
$8.44 - $12.49 $1,325 - $1,960
157 Added 2.96%
5,464 $47,000
Q4 2021

Feb 11, 2022

BUY
$10.12 - $14.07 $3,116 - $4,333
308 Added 6.16%
5,307 $60,000
Q3 2021

Feb 11, 2022

BUY
$7.25 - $13.23 $1,725 - $3,148
238 Added 5.0%
4,999 $63,000
Q2 2021

Feb 11, 2022

BUY
$8.0 - $9.75 $38,088 - $46,419
4,761 New
4,761 $39,000

Others Institutions Holding GOSS

About Gossamer Bio, Inc.


  • Ticker GOSS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 93,954,000
  • Market Cap $72.3M
  • Description
  • Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...
More about GOSS
Track This Portfolio

Track State Of Wyoming Portfolio

Follow State Of Wyoming and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Wyoming, based on Form 13F filings with the SEC.

News

Stay updated on State Of Wyoming with notifications on news.